Addiction is a scourge plaguing communities across the nation, spanning all socioeconomic backgrounds, and devastating countless families and individuals both young and old. Every day, opioid abuse claims the lives of over 130 innocent people–it is an epidemic that has been compounded by the COVID-19 pandemic and requires an all hands on deck response.
Joe believes solving this crisis requires a comprehensive, multi-faceted approach. That’s why in Congress, he is working to make bold investments in addiction prevention, treatment, and recovery initiatives that help stem the tide of opioid abuse and put people on the path to success.
In Congress, Joe has co-sponsored the following legislation:
H.R. 2366 - STOP Fentanyl Act
Establishes programs to address addiction and overdoses caused by illicit fentanyl and other opioids.
H.R. 4323 - Excellence in Mental Health and Addiction Treatment Act of 2021
Gives all states the ability to fund Certified Community Behavioral Health Centers (CCBHC), to expand access to high-quality mental health and addiction services.
Comprehensive Addiction Resources Emergency Act
Provides funding to help states with the highest levels of overdoses, as well as funding for public health surveillance, research, provider training, and access to reversal medications.
H.R. 909, Moms Matter Act
Establishes two grant programs to address maternal mental health conditions and substance use disorder, with a focus on racial and ethnic minority groups.
H.R. 1368, Mental Health Justice Act
Creates grant program for states and local governments to train and dispatch mental health professionals to respond to emergencies that involve people with behavioral health needs.
H.R. 4341, CARA 3.0 Act of 2021
Increases funding authorization levels for the Comprehensive Addiction and Recovery Act (CARA) programs enacted in 2016.
H.R. 3259, NOPAIN Act
Establishes separate payment for certain non-opioid treatments under Medicare that replace or reduce opioid consumption.
H.R. 1384, Mainstreaming Addiction Treatment Act
Removes the requirement that a HCP apply for a separate waiver through the DEA to dispense certain drugs for maintenance or detoxification treatment.